RYLEE NORTHEIM: Open Payments
NPI 1457963472 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 24 payments from 13 companies in 2025. Trend: 2023 $18 · 2024 $295 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $42 |
| Amgen Inc. | 2 | $41 |
| Genentech USA, Inc. | 1 | $30 |
| Organon LLC | 4 | $29 |
| Incyte Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Biocon Biologics Inc | 1 | $24 |
Products named: SKYRIZI, DUPIXENT, ILUMYA, TREMFYA, Otezla, Xolair, VTAMA, OPZELURA.
Industry payments across OH — which companies pay providers there.
